| Spring Hill Health And Rehabilitation Center | |
| 12170 Cortez Blvd, Brooksville, Florida 34613 | |
| (352) 597-5100 | |
| Name | Spring Hill Health And Rehabilitation Center |
|---|---|
| Location | 12170 Cortez Blvd, Brooksville, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 95.75% |
| Medicare ID (CCN) | 105996 |
| Legal Business Name | 12170 Cortez Boulevard Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1114973740 |
| Organization Name | SPRING HILL HEALTH CARE ASSOCIATES LLC |
| Doing Business As | SPRING HILL HEALTH AND REHABILITATION CENTER |
| Address | 12170 Cortez Blvd, Brooksville, FL 34613 |
| Phone Number | 352-597-5100 |
News Archive
Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.
Santarus, Inc., a specialty biopharmaceutical company, today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.
After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?
Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin discusses USAID Administrator Rajiv Shah's second annual letter in this GHTC "Breakthroughs" blog post, writing, "Shah rightly emphasizes the role of science, technology, and innovation in meeting USAID's international health goals."
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
› Verified 5 days ago
| NPI Number | 1497024269 |
| Organization Name | 12170 CORTEZ BOULEVARD OPERATIONS LLC |
| Doing Business As | SPRING HILL HEALTH AND REHABILITATION CENTER |
| Address | 12170 Cortez Blvd, Brooksville, FL 34613 |
| Phone Number | 352-597-5100 |
News Archive
Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.
Santarus, Inc., a specialty biopharmaceutical company, today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.
After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?
Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin discusses USAID Administrator Rajiv Shah's second annual letter in this GHTC "Breakthroughs" blog post, writing, "Shah rightly emphasizes the role of science, technology, and innovation in meeting USAID's international health goals."
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
› Verified 5 days ago
| NPI Number | 1508638834 |
| Organization Name | 12170 CORTEZ BLVD OPCO LLC |
| Doing Business As | ASPIRE AT SPRING HILL |
| Address | 12170 Cortez Blvd, Brooksville, FL 34613 |
| Phone Number | 352-597-5100 |
News Archive
Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.
Santarus, Inc., a specialty biopharmaceutical company, today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.
After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?
Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin discusses USAID Administrator Rajiv Shah's second annual letter in this GHTC "Breakthroughs" blog post, writing, "Shah rightly emphasizes the role of science, technology, and innovation in meeting USAID's international health goals."
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.
Santarus, Inc., a specialty biopharmaceutical company, today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.
After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?
Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin discusses USAID Administrator Rajiv Shah's second annual letter in this GHTC "Breakthroughs" blog post, writing, "Shah rightly emphasizes the role of science, technology, and innovation in meeting USAID's international health goals."
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.23 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.36 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.98 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 8.37 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.51 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 3.61 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.94 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.94 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 40.84 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 31.93 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 18.09 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.84 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 54.07 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.97 | 82.93 |
News Archive
Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.
Santarus, Inc., a specialty biopharmaceutical company, today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.
After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?
Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin discusses USAID Administrator Rajiv Shah's second annual letter in this GHTC "Breakthroughs" blog post, writing, "Shah rightly emphasizes the role of science, technology, and innovation in meeting USAID's international health goals."
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
› Verified 5 days ago
Brooksville Healthcare Center Location: 1114 Chatman Blvd, Brooksville, Florida 34601 Phone: (352) 796-6701 | |
Heron Pointe Health And Rehabilitation Location: 1445 Howell Ave, Brooksville, Florida 34601 Phone: (352) 799-1451 | |
Northbrook Center For Rehabilitation And Healing Location: 575 Lamar Ave, Brooksville, Florida 34601 Phone: (352) 799-2226 | |
Spring Hill Health And Rehabilitation Center Location: 12170 Cortez Blvd, Brooksville, Florida 34613 Phone: (352) 597-5100 | |
Oak Hill Health & Rehabilitation Location: 7371 Cortez Oaks Blvd, Brooksville, Florida 34613 Phone: (765) 664-5400 |